{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:32:28Z","timestamp":1793619148169,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The neutrophil-to-lymphocyte ratio (NLR) is an accessible marker of systemic inflammation. However, its prognostic value for inpatient gout recurrence, particularly in comparison with traditional biomarkers, remains unclear. This study aims to investigate the association of NLR with inpatient gout recurrence, and compare its performance with traditional markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this international, multicenter retrospective cohort study, hospitalized patients with gout were enrolled from the GoutRe cohort (China, 2010-2025) and MIMIC-IV cohort (USA, 2008-2019). Restricted cubic spline, Cox regression and competing risk models were deployed to visualize and assess the association of NLR with inpatient gout recurrence risk. Model performance was evaluated using the C-statistic, net reclassification improvement, and decision curve analysis. Multiple machine learning algorithms were employed for external validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 7,603 patients (GoutRe: 5,584; MIMIC-IV: 2,019), elevated NLR (&amp;gt;2.69) was independently associated with a higher inpatient gout recurrence risk (GoutRe: HR\u00a0=\u00a02.05; MIMIC-IV: HR\u00a0=\u00a02.84; both\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;\u00a00.001). NLR correlated with systemic inflammation, comorbidities, and use of diuretics\/\u03b2-blockers. It outperformed serum uric acid (UA) and C-reactive protein (CRP) in predicting inpatient gout recurrence (AUC: 0.62\n                      <jats:italic>vs.<\/jats:italic>\n                      0.59 and 0.61, respectively), with improved accuracy when combined with UA (AUC\u00a0=\u00a00.65,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;\u00a00.01). Predictive value remained consistent across subgroups, including those with normal UA, no tophus, and ongoing anti-inflammatory or urate-lowering therapy. Machine learning models, particularly XGBoost, confirmed NLR\u2019s predictive strength. Incorporation of NLR into baseline models improved discrimination and reclassification. Decision curve analysis showed greater net clinical benefit with NLR-based models. Biological plausibility analysis revealed that elevated NLR reflected neutrophilia and lymphopenia, indicative of systemic inflammation during the intercritical period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated NLR is a robust, accessible biomarker independently associated with inpatient gout recurrence. Its integration into clinical risk models enhances prediction accuracy and supports personalized inpatient gout recurrence prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1688516","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T06:31:58Z","timestamp":1762756318000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Neutrophil-to-lymphocyte ratio predicts inpatient gout recurrence: a large-scale multicenter retrospective cohort with machine-learning validation"],"prefix":"10.3389","volume":"16","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danning","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24","article-title":"Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"6","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"106156","DOI":"10.1016\/j.jinf.2024.106156","article-title":"Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection","volume":"88","author":"Gu","year":"2024","journal-title":"J Infect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.11390","article-title":"Association between gout flare and subsequent cardiovascular events among patients with gout","volume":"328","author":"Cipolletta","year":"2022","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.05.033","article-title":"Controversies and practical management of patients with gout and chronic kidney disease","volume":"106","author":"Johnson","year":"2024","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.42480","article-title":"Risk of venous thromboembolism with gout flares","volume":"75","author":"Cipolletta","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01092-x","article-title":"The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout","volume":"20","author":"Yokose","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13018-023-03536-8","article-title":"Acute gout attacks during the perioperative period and risk factors of recurrence after orthopedic surgery among untreated gout patients","volume":"18","author":"Wang","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/art.42986","article-title":"Short-term risk of cardiovascular events in people newly diagnosed with gout","volume":"77","author":"Cipolletta","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00816-1","article-title":"Critical appraisal of serum urate targets in the management of gout","volume":"18","author":"Stamp","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2203385","article-title":"Gout","volume":"387","author":"Mikuls","year":"2023","journal-title":"New Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01137-1","article-title":"The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies","volume":"20","author":"Leask","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26640","article-title":"Serum urate and recurrent gout","volume":"331","author":"McCormick","year":"2024","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2009.00851.x","article-title":"Monosodium urate crystals in inflammation and immunity","volume":"233","author":"Shi","year":"2010","journal-title":"Immunol Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00319-2","article-title":"Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials","volume":"4","author":"Stamp","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.43215","article-title":"Gout and NLRP3 inflammasome biology","volume":"77","author":"Poulsen","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.04.006","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus","volume":"36","author":"Wu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.42333","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers in axial spondyloarthritis: observational studies from the program to understand the longterm outcomes in spondyloarthritis registry","volume":"75","author":"Sen","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S408929","article-title":"Joint application of multiple inflammatory cytokines in diagnosis of gout flare","volume":"16","author":"Yu","year":"2023","journal-title":"J Inflammation Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.42523","article-title":"Prediagnostic glycoprotein acetyl levels and incident and recurrent flare risk accounting for serum urate levels: A population-based, prospective study and Mendelian randomization analysis","volume":"75","author":"Joshi","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-025-04454-8","article-title":"Development and validation of a multidimensional and interpretable artificial intelligence model to predict gout recurrence in hospitalized patients: a real-world, multicentre cohort study in China","author":"Li","year":"2025","journal-title":"BMC Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814378","article-title":"Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte\/HDL-cholesterol ratio) in acute myocardial infarction and particularities in young patients","volume":"24","author":"Tudurachi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030242","article-title":"Correlation of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and mean platelet volume (MPV) with gout activity: A monocentric and retrospective study","volume":"101","author":"Wu","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B29","first-page":"1","article-title":"Implementation of the international statistical classification of diseases and related health problems, tenth revision (ICD-10)","volume":"18","year":"1997","journal-title":"Epidemiol Bull"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S432898","article-title":"New inflammatory marker associated with disease activity in gouty arthritis: the systemic inflammatory response index","volume":"16","author":"Jiang","year":"2023","journal-title":"J Inflammation Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S272797","article-title":"Development and validation of nomograms for predicting cancer-specific survival in elderly patients with intrahepatic cholangiocarcinoma after liver resection: A competing risk analysis","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: users' Guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41467-021-20935-9","article-title":"Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors","volume":"12","author":"Valero","year":"2021","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13400","article-title":"Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab","volume":"21","author":"Sargin","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00787-0","article-title":"Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases","volume":"23","author":"Wigerblad","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247616","article-title":"Gout and hyperuricemia: A narrative review of their comorbidities and clinical implications","volume":"13","author":"Timsans","year":"2024","journal-title":"J Clin Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.37","article-title":"C-reactive protein in rheumatology: biology and genetics","volume":"7","author":"Rhodes","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160452","article-title":"Serum uric acid and the\u00a0risk of incident and recurrent gout: A systematic review","volume":"44","author":"Shiozawa","year":"2017","journal-title":"J Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o1754","article-title":"Gout: diagnosis and management-summary of NICE guidance","volume":"378","author":"Neilson","year":"2022","journal-title":"BMJ"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead139","article-title":"Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack","volume":"62","author":"Zhao","year":"2023","journal-title":"Rheumatol (Oxford)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1688516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T06:32:02Z","timestamp":1762756322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1688516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2025.1688516"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1688516","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"1688516"}}